Mounjaro 10 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FM14B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,741
Award facts
- Contract value 100% obligated
- $11,741.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,741.35 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 ml pen injectors on November 17, 2025, with an ultimate completion date of November 18, 2025. This non-set-aside award was competitively procured and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor.
This delivery order exemplifies AmerisourceBergen's critical role in supporting federal medical supply chains, particularly for military and veteran healthcare systems. Mounjaro is a diabetes medication supplied through the DLA's pharmaceutical distribution network to support Department of Defense health programs. AmerisourceBergen's SPE2DX prime vendor contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a diverse range of medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent receipt of competitively awarded delivery orders across various pharmaceutical products demonstrates its established capability to fulfill federal medical procurement requirements efficiently.
Quick answers
Who was awarded contract SPE2DR26FM14B?
SPE2DR26FM14B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FM14B worth?
The government has obligated $11,741 on SPE2DR26FM14B.
Is contract SPE2DR26FM14B an order under another contract?
Yes. SPE2DR26FM14B is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM14B competed?
The extent of competition for SPE2DR26FM14B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award